Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102641 · ClinicalTrials.gov registry record · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
A Phase 4 study of Post Operative Pain and Cesarean Delivery, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 825
- Enrollment target
- 1
- Study location
NCT07102641 is a Phase 4 study of Post Operative Pain and Cesarean Delivery that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 825 participants, above the 222-participant average among 56 other Post Operative Pain trials with a reported enrollment target (272% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07102641, a Phase 4 study of Post Operative Pain and Cesarean Delivery, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 825 participants
- Enrollment target
- 1
- Study location
Study Summary
Cesarean delivery is a commonly performed surgical procedure associated with worse postpartum pain when compared to vaginal birth. Uncontrolled postpartum pain is associated with increased neonatal and maternal risks. Multimodal non-opioid pain medications, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) are the preferred first-line therapies. There is no standard practice, however, on best dosing schedules (ie staggered or different time v. simultaneous or same time). This protocol describes a randomized clinical trial aimed to determine whether staggered dosing of acetaminophen and NSAIDs in superior to simultaneous dosing in controlling post-cesarean pain.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG NSAID (Ketorolac/Ibuprofen)
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2025-08-26 |
| Est. Completion | 2027-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07102641
The ClinicalTrials.gov registry entry for NCT07102641 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 825 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 222-participant average among 56 other Post Operative Pain trials with a reported enrollment target (272% higher). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which Acetaminophen is the first listed.
NCT07102641 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07102641 about?
NCT07102641 is a clinical study titled "Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies". Cesarean delivery is a commonly performed surgical procedure associated with worse postpartum pain when compared to vaginal birth. Uncontrolled postpartum pain is associated with increased neonatal and maternal risks. Multimodal non-opioid pain medications, including acetaminophen and non-steroidal ...
What is the current status of trial NCT07102641?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 825 participants. The study started on 2025-08-26. Estimated completion is 2027-12.
What conditions does trial NCT07102641 study?
This clinical trial studies the following conditions: Post Operative Pain, Cesarean Delivery, Postpartum Pain, Postpartum Comfort, NSAIDs.
What interventions are being tested in trial NCT07102641?
The interventions under investigation include: Acetaminophen (DRUG), NSAID (Ketorolac/Ibuprofen) (DRUG).
Who is sponsoring clinical trial NCT07102641?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102641 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
-
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
RECRUITING · Phase 4
-
Post Operative Infusion Pump Pain Study
RECRUITING · Phase 4
-
ZYNRELEF for Pain Management in Total Knee Arthroplasty
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.